To sell a new drug, it may be time to get inVentiv. inVentiv Health provides commercial, clinical, communications, and patient assistance services for 550 customers in the life sciences, biotech, and pharmaceutical industries. Its Commercial segment provides outsourced sales and marketing services, market research, data collection and management, recruitment, and training. The Clinical segment provides clinical staffing, clinical research and statistical analysis, and executive placement. It has served such notable clients as Johnson and Johnson, Bristol-Myers Squibb, and Novartis Pharmaceuticals. inVentiv is owned by private equity firms Thomas H. Lee Partners (THL) and Advent International.